Lipid rafts: a signaling platform linking cholesterol metabolism to synaptic deficits in autism spectrum disorders. - Test2 - elhamkhani - TriplyDB

Lipid rafts: a signaling platform linking cholesterol metabolism to synaptic deficits in autism spectrum disorders.

Lipid rafts: a signaling platform linking cholesterol metabolism to synaptic deficits in autism spectrum disorders.

http://www.wikidata.org/entity/Q37681389

about

Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes Fragile X mental retardation protein: from autism to neurodegenerative disease.Autism spectrum disorders: emerging mechanisms and mechanism-based treatment.Comparative two-dimensional polyacrylamide gel electrophoresis of the salivary proteome of children with autism spectrum disorder.Altered cholesterol biosynthesis causes precocious neurogenesis in the developing mouse forebrain.Modulation of the Isoprenoid/Cholesterol Biosynthetic Pathway During Neuronal Differentiation In Vitro.Can Cholesterol Metabolism Modulation Affect Brain Function and Behavior?

P2860

Q27023257-196FF36D-30BC-4C62-9D87-E2A1B6034745 Q35077291-D68E4BA1-5B70-4BE7-B952-31D7411AAC1A Q35595728-5FD42BC2-9A5A-43A3-BF8D-FBC926DA723D Q36232865-7487A403-E239-48E6-AAF9-AE7F6A59192F Q36880275-61DADD95-9B5B-4E8F-8B52-D92653F13F53 Q38759135-52DB9041-6470-43F4-9D23-472FD15C3C1A Q38896297-AEB2EDDA-14C5-41AB-B5D9-98CD89306EFC

P2860

Lipid rafts: a signaling platform linking cholesterol metabolism to synaptic deficits in autism spectrum disorders.

http://www.wikidata.org/entity/Q37681389

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Lipid rafts: a signaling platf ...... in autism spectrum disorders.

@en

Lipid rafts: a signaling platf ...... in autism spectrum disorders.

@nl

type

label

Lipid rafts: a signaling platf ...... in autism spectrum disorders.

@en

Lipid rafts: a signaling platf ...... in autism spectrum disorders.

@nl

prefLabel

Lipid rafts: a signaling platf ...... in autism spectrum disorders.

@en

Lipid rafts: a signaling platf ...... in autism spectrum disorders.

@nl

P1433

Q37681389-397B0F26-A422-443A-8CFE-2D6D495D3E51

P1476

Q37681389-67999566-AA75-4E6C-AED4-FA1258821569

P2093

Q37681389-15851322-9DD0-4CFC-BF8E-1F16DFBCA02D

P2860

Q37681389-03EA9136-51FC-4268-A9B2-B34F98883620

Q37681389-0E3C9ED2-34BE-447D-9FC0-87B55228174D

Q37681389-10DDB898-3117-4BC4-A084-3292817F1CF5

Q37681389-121BD617-484C-4A39-803D-334A21A6C083

Q37681389-1E69A8AD-FC02-4F1F-9332-4EAC7B98BC61

Q37681389-25BD27DC-0513-4C0B-AC42-EA41C6C2FBE5

Q37681389-2E067360-81AD-4303-9DBA-FF8D6D7DCCC3

Q37681389-4B0B14BA-707E-469B-8F30-87FEF6C795C3

Q37681389-4CBA98DB-C432-4F59-AF01-18C26B32BF8D

Q37681389-4CF042B6-1705-4FF7-B32B-A41648F624A1

P304

Q37681389-07A52C03-F240-4F08-B6F1-24C3B0E2A314

P31

Q37681389-3dc9d0c0-5b01-41ce-a80b-799692758699

Q37681389-40009500-CAF7-479A-B58D-28613AB6F106

P356

Q37681389-BA701650-4383-48F7-9BA9-FDA35EFE5D11

P478

Q37681389-6AA803CE-8C41-40DA-A466-90E710656ECD

P577

Q37681389-CC2F8BAB-1502-4143-82DF-F9341E3E99A1

P5875

Q37681389-177EB684-88F9-445E-8067-32C63FB65156

P698

Q37681389-99AC3352-118E-4C99-ABE2-DCD2E1805115

P921

Q37681389-4C66B22F-4FBB-4948-A0A2-BAFC9F860F79

Q37681389-FEA10DEE-F95A-4782-A78E-ABCB77223744

P932

Q37681389-4B4B036E-CC41-4CF2-81E0-13DEB819840C

P356

FNBEH.2014.00104

P1433

Frontiers in Behavioral Neuroscience

P1476

Lipid rafts: a signaling platf ...... in autism spectrum disorders.

@en

P2093

Hansen Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Cholesterol, lipid rafts, and disease

Lipid rafts, cholesterol, and the brain

Channelopathy pathogenesis in autism spectrum disorders

Lipid rafts and signal transduction

Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization

Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor

The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1

The mGluR theory of fragile X mental retardation

Lipid rafts as a membrane-organizing principle

The postsynaptic architecture of excitatory synapses: a more quantitative view

P304

104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNBEH.2014.00104

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261605456

http://www.w3.org/2001/XMLSchema#string

P698

24723866

http://www.w3.org/2001/XMLSchema#string

P921

Autism spectrum

P932

3973904

http://www.w3.org/2001/XMLSchema#string